Works in Hematological Oncology, 2023, Vol 41, Issue 1
Results: 27
DNA damage accumulation and repair defects in FLT3‐ITD acute myeloid leukemia: Implications for clonal evolution and disease progression.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 26, doi. 10.1002/hon.3076
- By:
- Publication type:
- Article
Association of cesarean section with risk of childhood leukemia: A meta‐analysis from an observational study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 182, doi. 10.1002/hon.3070
- By:
- Publication type:
- Article
Convalescent plasma in oncohematological patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 208, doi. 10.1002/hon.3069
- By:
- Publication type:
- Article
High mortality in fully vaccinated hematologic patients treated with anti‐CD20 antibodies during the "Omicron wave" of COVID‐19 pandemic.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 205, doi. 10.1002/hon.3064
- By:
- Publication type:
- Article
Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 159, doi. 10.1002/hon.3099
- By:
- Publication type:
- Article
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 39, doi. 10.1002/hon.3098
- By:
- Publication type:
- Article
Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignancies.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 167, doi. 10.1002/hon.3097
- By:
- Publication type:
- Article
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
- By:
- Publication type:
- Article
Competitive evolved sub‐clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 178, doi. 10.1002/hon.3095
- By:
- Publication type:
- Article
Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 147, doi. 10.1002/hon.3094
- By:
- Publication type:
- Article
Exosomal NAMPT from chronic lymphocytic leukemia cells orchestrate monocyte survival and phenotype under endoplasmic reticulum stress.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 61, doi. 10.1002/hon.3093
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 128, doi. 10.1002/hon.3092
- By:
- Publication type:
- Article
The applicability of the Second Revision of the International Staging System for patients with multiple myeloma receiving immunomodulatory drugs or proteasome inhibitor‐based regimens as induction treatment: A real‐world analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 139, doi. 10.1002/hon.3090
- By:
- Publication type:
- Article
A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 108, doi. 10.1002/hon.3089
- By:
- Publication type:
- Article
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 50, doi. 10.1002/hon.3087
- By:
- Publication type:
- Article
Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 3, doi. 10.1002/hon.3086
- By:
- Publication type:
- Article
Predictors of clinical evolution of SARS‐CoV‐2 infection in hematological patients: A systematic review and meta‐analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 16, doi. 10.1002/hon.3084
- By:
- Publication type:
- Article
Autologous hematopoietic cell transplantation versus whole‐brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta‐analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 88, doi. 10.1002/hon.3083
- By:
- Publication type:
- Article
The elderly prognostic index predicts early mortality in older patients with diffuse large B‐cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 78, doi. 10.1002/hon.3081
- By:
- Publication type:
- Article
Reply to "successful early use of anti‐SARS‐CoV‐2 monoclonal neutralizing antibodies in SARS‐CoV‐2 infected hematological patients—A Czech multicenter experience": A case series of SARS‐CoV‐2 Omicron infection and aggressive lymphoma in the Sotrovimab era
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 213, doi. 10.1002/hon.3079
- By:
- Publication type:
- Article
Long term outcomes of gastric mucosa‐associated lymphoid tissue lymphoma treated with radiotherapy: A multi‐center retrospective cohort study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 71, doi. 10.1002/hon.3078
- By:
- Publication type:
- Article
Effects of the BTN162b2 mRNA COVID‐19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 120, doi. 10.1002/hon.3077
- By:
- Publication type:
- Article
Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 196, doi. 10.1002/hon.3061
- By:
- Publication type:
- Article
Response to SARS‐CoV‐2 vaccination and antibodies persistence in multiple myeloma patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 210, doi. 10.1002/hon.3051
- By:
- Publication type:
- Article
Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 201, doi. 10.1002/hon.3047
- By:
- Publication type:
- Article
Diffuse large B‐cell lymphoma of the Waldeyer's ring: A U.S. population‐based survival analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 192, doi. 10.1002/hon.3059
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 1, doi. 10.1002/hon.3018
- Publication type:
- Article